Clinical Trial Update: Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.

View source ↗

Summary

Pfizer-sponsored observational study on clinical and anthropometric features of children with Achondroplasia was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Snippet

Sponsor: Pfizer | Conditions: Achondroplasia | Status: TERMINATED | Results posted: 2024-10-17